Status | Study |
Recruiting |
Study Name: Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcomas Condition: Myxoid Liposarcoma of Soft Tissue Date: 2014-03-06 Interventions: Radiation: dose reduction of preoperative radiotherapy in MLS A: The primary sarcoma in case of non-meta |
Recruiting |
Study Name: SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Refractory Liposarcoma, Osteogenic Sarcoma, and Ewing Sarcomas Condition: Liposarcoma Osteogenic Sarcoma Date: 2014-01-10 Interventions: Drug: Regorafenib Drug: Placebo |
Recruiting |
Study Name: Ph II Cabazitaxel DD Liposarcoma Condition: Dedifferentiated Liposarcoma Date: 2013-07-30 Interventions: Drug: Cabazitaxel Other Name: |
Recruiting |
Study Name: Trial of Nilotinib and Adriamycin as Treatment in Liposarcomas and Leiomyosarcomas of Retroperitoneum Condition: Retroperitoneal Liposarcoma Retroperitoneal Leiomyosarcoma Date: 2013-07-17 Interventions: Drug: Nilotinib-adriamycin The nilotinib-adriamycin combination will be given in 4 cycles of 21 days. In |
Active, not recruiting |
Study Name: Assessment of Helical Tomotherapy Radiotherapy (54 Gy) Followed by Surgery in Retro-peritoneal Liposarcoma Condition: Liposarcoma Date: 2012-11-05 Interventions: Radiation: Radiotherapy Evaluation of the efficacy of the combination with radio-surgery helical tomothe |
Terminated |
Study Name: Efficacy and Safety of Plitidepsin in Patients With Advanced Unresectable or Metastatic, Relapsed/Refractory, Dedifferentiated Liposarcoma (DLPS): an Exploratory Phase II Multicenter Trial Condition: Adult Patients With Unresectable Locally Advanced or Metastatic, Relapsed/Refractory Dedifferentiated Liposarcoma Date: 2012-10-29 Interventions: Drug: plitidepsin |
Active, not recruiting |
Study Name: Activity and Tolerability of Pazopanib in Advanced and/or Metastatic Liposarcoma. A Phase II Clinical Trial Condition: Advanced and / or Metastatic Liposarcoma Date: 2012-09-14 Interventions: Drug: Pazopanib Patients will receive oral pazopanib, 800mg once daily and treatment will continue until |
Active, not recruiting |
Study Name: A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma Condition: Advanced or Metastatic Liposarcoma or Leiomyosarcoma Date: 2012-08-06 Interventions: Drug: Trabectedin Type=exact n |
Completed |
Study Name: A Trial of Oral 5-azacitidine in Combination With Romidepsin in Advanced Solid Tumors, With an Expansion Cohort in Virally Mediated Cancers and Liposarcoma Condition: Solid Tumors Virally Mediated Cancers and Liposarcoma Date: 2012-02-08 Interventions: Drug: oral 5-azacitidine in combination with romidepsin DO |
Completed |
Study Name: Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma Condition: Liposarcoma Surgically Unresectable Lipos Date: 2012-01-06 Interventions: Drug: pazopanib Pazopanib 800 mg orally once daily will be started on Cycle 1 Day 1 and will be administ |